KEAP1 and non-small cell lung carcinoma: In many cases of non-small cell lung cancer (NSCLC), constitutive activation of Nrf2 in the nucleus caused by the loss-of-function KEAP1 genetic mutation prevents redox stress accumulation triggered by chemotherapy [24].